Is it a doctor's job to get the best outcomes for their patients or to tell the truth? What happens when these two things are ...

Thea, the AI-powered personalized learning platform headquartered in Arlington, Virginia, today announced that it has ...

A DNA‑based test of the tumour can help two‑thirds of certain breast cancer patients safely avoid chemotherapy without ...

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes ...

The Prosigna genomic test may help identify breast cancer patients who are likely to gain little benefit from chemotherapy ...

In cardiology, sex and gender-sensitive diagnosis and treatment planning are crucial, but biological differences remain the ...

Each of my stories includes an original artwork. Clicking on them will take you to their websites. I am grateful for all the ...

Advanced brain imaging using a next-generation tau tracer revealed more Alzheimer’s-related pathology than current methods, ...

RASolute 302 showed daraxonrasib reduced mortality risk by 60% versus chemotherapy in previously treated metastatic PDAC, with median OS 13.2 versus 6.7 months. OPTIMA found Prosigna-defined low-risk ...

Scientists developed a DNA or gene test that can differentiate between patients who are likely to benefit from the treatment and those who are not, a clinical trial has shown.

A pioneering blood test that can detect more than 50 cancers before symptoms appear could save tens of thousands of lives a ...